Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area ubiquitination proteasome ubiquitination'

Search results for: 'research area ubiquitination proteasome ubiquitination'

Items 41-50 of 69

Page
per page
  1. E-64
    A2576 E-64
     2 Citation
    Target: Cathepsins|Calpains|Papains
    Summary: Cysteine protease inhibitor,irriversible
      ≥49.1 mg/mL
  2. Calpain Inhibitor I, ALLN
    A2602 Calpain Inhibitor I, ALLN
     2 Citation
    Target: Cathepsins|Calpains
    Summary: Calpain I/II/ B/L inhibitor
  3. LY-411575
    A4019 LY-411575
    Summary: Gamma secretase inhibitor
      ≥23.85 mg/mL
  4. Sitagliptin phosphate monohydrate
    A4036 Sitagliptin phosphate monohydrate
     5 Citation
    Target: DPP-4
    Summary: Potent DPP-4 inhibitor
      ≥23.8 mg/mL
  5. Alogliptin (SYR-322)
    A4038 Alogliptin (SYR-322)
     1 Citation
    Target: DPP-4
    Summary: DPP-4 inhibitor,potent and highly selective
  6. PD 150606
    A4413 PD 150606
    Target: Calpains
    Summary: Non-peptide calpain inhibitor
      Soluble in DMSO
  7. SID 26681509
    A4424 SID 26681509
    Target: Cathepsins
    Summary: Human cathepsin L inhibitor,potent and reversible
      <26.98 mg/mL
  8. WAY 170523
    A4442 WAY 170523
    Target: MMP
    Summary: MMP-13 inhibitor,potent and selective
      <61.37 mg/mL
  9. Leupeptin, Microbial
    A2570 Leupeptin, Microbial
    Target: Cathepsins|Calpains|Trypsins
    Summary: Inhibitor of serine and cysteine proteases
      ≥24.7 mg/mL
  10. YO-01027 (Dibenzazepine, DBZ)
    A4018 YO-01027 (Dibenzazepine, DBZ)
     1 Citation
    Summary: γ-secretase inhibitor
      ≥23.17 mg/mL

Items 41-50 of 69

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Proteases 42item
  2. Apoptosis 2item
  3. Chromatin/Epigenetics 1 item
  4. Metabolism 10item
  5. DNA Damage/DNA Repair 2item
  6. PI3K/Akt/mTOR Signaling 1 item
  7. Microbiology & Virology 5item
  8. Cell Cycle/Checkpoint 1 item
  9. Ubiquitination/ Proteasome 25item
  10. Neuroscience 1 item
  11. Immunology/Inflammation 2item
Reversibility
  1. Reversible 12item
  2. Irreversible 6item
Target
  1. Proteasome 11item
  2. Cathepsins 10item
  3. Histone Deacetylases (HDACs) 1 item
  4. PI3K 2item
  5. MDM2 1 item
  6. MMP 3item
  7. Thymidylate Synthase 1 item
  8. Deubiquitinating enzymes (DUBs) 1 item
  9. Aminopeptidases 2item
  10. Microtubules/Tubulins 2item
  11. HSP90 4item
  12. Renin 1 item
  13. HIV proteases 1 item
  14. Pepsins 1 item
  15. Vacuolar-type ATPase 1 item
  16. Calpains 5item
  17. Ubiquitin-specific proteases 1 item
  18. Trypsins 1 item
  19. Trypsin 1 item
  20. Chymotrypsin 1 item
  21. Kallikrein 1 item
  22. Trypsinogen 1 item
  23. HIV-1 gp120 1 item
  24. Fatty-acid-binding proteins (FABPs) 1 item
  25. Autophagy 1 item
  26. 20S proteasomal chymotrypsin 1 item
  27. Geranylgeranyltransferase I 1 item
  28. Farnesyltransferase 1 item
  29. Aldehyde Dehydrogenases 1 item
  30. IL Receptors 1 item
  31. CCL2 1 item
  32. Papains 1 item
  33. DPP-4 3item
  34. ADAMs 1 item
  35. Ub-conjugating enzyme (E2) complex 1 item
  36. P97 ATPase 1 item
Reported Experiments
  1. Animal Experiments 63item
  2. Cell Experiments 41item
Related Disease
  1. Breast Cancer 13item
  2. Cancer 39item
  3. Cocaine-Related Disorders 1 item
  4. Colon Cancer 4item
  5. Colon Carcinoma 1 item
  6. Colorectal Cancer 2item
  7. Diabetes 3item
  8. Glioblastoma 1 item
  9. Glioma 1 item
  10. HIV 1 item
  11. HIV Infections 2item
  12. Inflammatory Diseases 2item
  13. Leukemia 2item
  14. Lung Cancer 2item
  15. Lymphoma 2item
  16. Mantle Cell Lymphoma 1 item
  17. Melanoma 4item
  18. Multiple Myeloma 5item
  19. Myeloma 3item
  20. Neuroblastoma 1 item
  21. Non-small Cell Lung Cancer 3item
  22. Ovarian Cancer 5item
  23. Pancreatic Cancer 2item
  24. Prostate Cancer 5item
  25. Psoriasis 1 item
  26. Renal Cell Carcinoma 1 item
  27. Rheumatoid Arthritis 2item
  28. Squamous Cell Carcinoma 1 item
  29. Type 2 Diabetes 1 item